300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Cryptocurrency
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Hong Kong
Nigeria
Sweden
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Oceania
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Pakistan
Sudan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Mozambique
Malta
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Bangladesh
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Huajin Capital, VC Fund

Huajin Capital

VC Fund

Zhuhai, China

Huajin Capital is a VC fund in Zhuhai focused on Biotechnology and Biopharma. Huajin Capital engages in equity investment, asset management, physical, and incubator.

Total investments:
46
Last investment:
Lead investor:
28%

Last updated:

Industries Huajin Capital invests in

BiotechnologyBiopharmaManufacturingMedicalHealth Care

Stages Huajin Capital invests in

Series ASeedSeries BSeries CSeries D

Countries Huajin Capital invests in

ChinaUnited States

Contacts

NameEmailPhoneSocials
Liu Feihong

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Biotechnology 9 (20%)
  • Biopharma 7 (15%)
  • Manufacturing 7 (15%)
  • Medical 6 (13%)
  • Health Care 5 (11%)
See all 38 industries →

Stage

  • Series A 10 (22%)
  • Seed 6 (13%)
  • Series B 6 (13%)
  • Series C 5 (11%)
  • Series D 4 (9%)
See all 10 stages →

Country

  • China 29 (63%)
  • United States 4 (9%)

Team

NameTitleInvestmentsLinksEmail
Liu Feihong Managing Director
Managing Director Total investments: 3 Find email

Investments

CompanyDescriptionRoundLinks
Dongsheng Fusion
Dongsheng Fusion is a magnetic confinement fusion technology company that develops miniaturized fusion power plant technology. $100M / Seed / Jun 08, 2026
Zhide New Energy Zhide New Energy
Zhide New Energy is a developer of high-capacity silicon anode materials for lithium batteries $87.8M / Series E / Apr 09, 2026
Zenitar Zenitar
Baoling Bio is an innovative drug research and development and industrialization service provider. The company's research and development pipeline covers the research and development of innovative drugs such as tumors (solid tumors and hematomas), autoimmune diseases, and cytokine storms caused by new coronavirus pneumonia. $86M / Series C / Jan 12, 2026
GigaAI GigaAI
Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space. $28.3M / Series A / Dec 08, 2025
HAAWKING HAAWKING
Haawking is a supplier of digital signal processors. Their products used in industrial control, motor drives, digital power supplies, photo voltaic, energy storage, new energy automotive and consumer electronics. Their customer can contact through mail id and phone number. Series B / Jun 17, 2025
HighlightLL Pharma HighlightLL Pharma
HighlightLL Pharma is a pharmaceutical company. $20.5M / Series C / Jan 03, 2025
SENASIC SENASIC
SENASIC focuses on the development, design and sales of high-performance chips and sensors related to automotive and industrial IoT applications. SENASIC's main products include the automotive tire pressure sensor series, the MAP sensor series and the industrial-grade wireless temperature sensor series for the Internet of Things. SENASIC hasmany years of technical accumulation and autonomous IP in low-power MCU, high-precision ADC, low-frequency 125kHz interface, acceleration detection interface, RF transmission and other core functional modules. SENASIC has accumulated a lot of experience in chip packaging, testing, calibration and reliability technology to ensure the automotive quality of sensor products. The company's automotive tire pressure sensor has reached AEC-Q10 Series D / Nov 26, 2024
Huali Juneng Huali Juneng
Huali Juneng is a pressure vessel and related equipment producer specializing in petroleum, chemical, oil, electricity, desalination, and medical. $110.6M / Seed / Nov 18, 2024
Bivision Bivision
Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment. $13.8M / Series A / Jul 26, 2024
Mellow Energy Mellow Energy
Mellow Energy Technology is a new calcium ore photovoltaic cell enterprise. Its business is the research and development, production and sales of centralized and distributed photovoltaic power stations. Seed / May 09, 2024
See all 46 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Cryptocurrency
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Hong Kong
Nigeria
Sweden
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Oceania
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Pakistan
Sudan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Mozambique
Malta
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Bangladesh
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Huajin Capital invest in?

Huajin Capital invests primarily in Biotechnology, Biopharma and Manufacturing startups, most often at Series A and Seed stage. Most of the 46 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Huajin Capital?

Public channels for Huajin Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Huajin Capital?

The team at Huajin Capital includes Liu Feihong (Managing Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Huajin Capital Huajin Capital Find emails